Sarepta Therapeutics Inc. Management Discusses Q2 2013 Results (Webcast)

Aug. 8.13 | About: Sarepta Therapeutics, (SRPT)

Sarepta Therapeutics (SRPT): Q2 EPS of -$0.46 beats by $0.17. Revenue of $3.0M misses by $2.08M. (PR)

The following audio is from an earnings conference call that will begin on August 8, 2013, at 8:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.